Figure 3.
Prevalence of trachomatous inflammation in children aged 0–5 years in communities randomized to standard (A) or enhanced (B) coverage. All communities received biannual mass azithromycin treatment in children less than 12 years of age.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.